We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03968419
Brief Title: This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. (CANOPY-N)

First Submitted : May 15, 2019
First Submitted that Met QC Criteria : May 29, 2019
First Posted : May 30, 2019

Certification/Extension First Submitted : July 5, 2022
Certification/Extension First Submitted that Met QC Criteria : July 5, 2022
Certification/Extension First Posted : July 6, 2022

Last Update Submitted that Met QC Criteria : September 27, 2022
Last Update Posted : October 4, 2022